AS 2020 DRAWS TO A CLOSE, there is little doubt that it will be regarded as an Annus Horribilis. Not just because of the toll the Covid-19 pandemic took on lives (64 million infected worldwide and 1.4 million dead) but also due to the devastation it caused to livelihoods, plunging the world into an economic trough not seen since the Great Depression. Yet, by the end of the year, amidst all the gloom, there emerged a silver lining that could yet make 2020 an Annus Mirabilis, thanks to the exciting development of vaccines to combat the pandemic.
Vaccines against diseases normally take years, if not decades, to develop. Not anymore. In a major breakthrough, on December 2, just nine months after the World Health Organization (WHO) had declared the Coronavirus disease or Covid-19 a pandemic, the United Kingdom cleared a vaccine developed by US pharma giant Pfizer in collaboration with German firm BioNTech SE for emergency use. Meanwhile, Pfizer, along with Moderna, a US-based biotech firm, which has developed a vaccine of its own, applied for an Emergency Use Authorisation certificate with the Food and Drug Administration (FDA), America’s health regulatory body. Both applicants claimed the effectiveness of treating the disease way above the 50 per cent stipulated by the FDA.
This story is from the December 14, 2020 edition of India Today.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the December 14, 2020 edition of India Today.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber? Sign In
AAMCHI ENGLISH
You'd think its history of language politics would have nixed such a possibility.
SULTANS OF AASMAN
It's harvest season for India's charter flight operators, as eager candidates hop on to rented choppers and small aircraft with sky-high ambitions.
Music to OUR EARS
After signing a record deal with Warner Music Group, Nora Fatehi sets her sights on being a global pop star
Rebel with a CAUSE
A retrospective of revolutionary artist Gobardhan Ash showcases four decades of his practice at the Kolkata Centre for Creativity
HYBRID FORMS
Mythic Femininities at DAG Delhi brings together a well-chosen crosssection of the late GOGI SAROJ PAL'S large body of work
OUT OF THE SHADOWS
JAI MEHTA makes his directorial debut with Disney+ Hotstar's web series Lootere
MAN OF MANY PARTS
Pratik Gandhi's transition from theatre and Gujarati cinema to mainstream Bollywood is an inspirational tale
THE DUNKI REPUBLIC
Rivers flowing down from the Himalayan massifs are known to have fickle habits-they curl about, meander and, if they stray far enough, get captured by bigger river systems.
A SENSE OF DEPRIVATION
As the Uddhav Sena gets a lion's share in the MVA seat-sharing deal, discontent brews within Congress ranks over the leadership conceding three key seats
Kshatriyas Declare War on Rupala
The minister's appeasement of Dalits has upset the warrior class, who want his candidature withdrawn or they will stir trouble for the BJP in all 26 seats